City View Green Holdings Inc. Stock OTC Markets
Stocks
CVGRF
CA1787182015
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0349 USD | +6.61% |
|
-0.57% | -53.34% |
| Market Cap | 3.09M 2.18M 1.92M 1.77M 1.63M 208M 3.15M 21.14M 8.29M 102M 8.2M 8.02M 354M | P/E 2024 |
-9.02x | P/E 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 3.27M 2.31M 2.02M 1.87M 1.72M 220M 3.32M 22.33M 8.76M 108M 8.66M 8.47M 374M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
84.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +6.61% | ||
| 1 week | -0.57% | ||
| Current month | +53.07% | ||
| 1 month | +42.45% | ||
| 3 months | +21.18% | ||
| 6 months | -36.31% | ||
| Current year | -53.34% |
| 1 week | 0.02 |  | 0.04 |
| 1 month | 0.01 | | 0.05 |
| Current year | 0.01 | | 0.18 |
| 1 year | 0 | | 0.18 |
| 3 years | 0 | | 0.3 |
| 5 years | 0 | | 0.66 |
| 10 years | 0 | | 1.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roberto Fia
CEO | Chief Executive Officer | 55 | - |
Sung Min Myung
DFI | Director of Finance/CFO | 40 | 2019-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Fia
BRD | Director/Board Member | 55 | 2014-11-09 |
Andrew Peterson
CHM | Chairman | 78 | - |
Steve Naraine
BRD | Director/Board Member | - | 2023-11-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.61% | -0.57% | - | - | 2.19M | |
| +0.95% | -0.08% | -12.93% | -8.82% | 12.85B | |
| +2.42% | +1.37% | -33.67% | -54.78% | 4.79B | |
| -0.02% | -0.64% | -7.44% | -9.90% | 4.4B | |
| +2.11% | -0.70% | +3.95% | -37.98% | 3.82B | |
| -7.84% | -7.31% | +11.66% | -9.08% | 3.68B | |
| -0.58% | +6.63% | -8.62% | -12.78% | 3.26B | |
| +0.28% | +0.57% | -11.17% | +2.10% | 3.1B | |
| -0.77% | +1.24% | -8.23% | -23.20% | 2.41B | |
| -0.32% | +4.78% | -5.15% | +44.22% | 1.8B | |
| Average | +0.28% | -1.14% | -7.95% | -12.25% | 4.46B | |
| Weighted average by Cap. | -0.01% | -1.26% | -9.82% | -15.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -388K -274K -240K -222K -205K -26.12M -395K -2.65M -1.04M -12.85M -1.03M -1.01M -44.38M | -1.06M -751K -659K -608K -562K -71.64M -1.08M -7.27M -2.85M -35.23M -2.82M -2.76M -122M |
| Net Debt | 68.01K 47.98K 42.13K 38.88K 35.9K 4.58M 69.2K 465K 182K 2.25M 180K 176K 7.78M | 174K 123K 108K 99.42K 91.81K 11.71M 177K 1.19M 466K 5.76M 461K 451K 19.89M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$0.0349 | +6.61% | 367,500 |
| 26-07-09 | US$0.0328 | +23.75% | 407,500 |
| 26-07-08 | US$0.0265 | -38.18% | 259,000 |
- Stock Market
- Stocks
- CVGR Stock
- CVGRF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
